Pantothenic acid
|
Basic information |
| Metabolite name | Pantothenic acid |
 | HMDB0000210 |
 |
C00864 |
 |
6613 |
| Synonyms | Pantothenate; |
| No. of studies | 23 |
|
Basic information |
| Metabolite name | Pantothenic acid |
| HMDB0000210 |
|
C00864 |
|
6613 |
| Synonyms | Pantothenate; |
| No. of studies | 23 |
|
Relationship between Pantothenic acid and depression (count: 23) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M006 | Type1 | depressed group vs. control group | Plasma | Human | Down |
| Study M007 | Type1 | CRS group vs. control group | Urine | Wistar rat | Up |
| Study M012 | Type1 | CVS group vs. control group | Urine | Wistar rat | Up |
| Study M012 | Type2 | CVS + fluoxetine group vs. CVS group | Urine | Wistar rat | Down |
| Study M012 | Type2 | CVS + CSGS group vs. CVS group | Urine | Wistar rat | Down |
| Study M053 | Type1 | CUMS group vs. control group | Urine | Wistar rat | Up |
| Study M062 | Type1 | CUMS group vs. control group | Cerebellum | Sprague-Dawley rat | Down |
| Study M1032 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M1072 | Type1 | CUMS group vs. control group | Faece | Cynomolgus monkey | Down |
| Study M1079 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Up |
| Study M208 | Type1 | GCI model group vs. control group | Hippocampus | ICR mouse | Down |
| Study M454 | Type1 | vascular depression model group vs. control group | Hippocampus | ICR mouse | Down |
| Study M454 | Type2 | vascular depression model + YXST group vs. vascular depression model group | Hippocampus | ICR mouse | Up |
| Study M555 | Type1 | FMT group vs. control group | Liver | Sprague-Dawley rat | Down |
| Study M569 | Type2 | LPS + HPF group vs. LPS group | Hippocampus | ICR mouse | Up |
| Study M592 | Type1 | CUMS group vs. control group, LC-MS | Liver | Sprague-Dawley rat | Down |
| Study M593 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Down |
| Study M593 | Type2 | CUMS + venlafaxine group vs. CUMS group | Liver | Sprague-Dawley rat | Up |
| Study M593 | Type2 | CUMS + high dose of Radix Bupleuri-Radix Paeoniae Alba herb pair group vs. CUMS group | Liver | Sprague-Dawley rat | Up |
| Study M598 | Type1 | MS group vs. control group | Brain | Sprague-Dawley rat | Down |
| Study M632 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Unknown |
| Study M806 | Type1 | CUMS group vs. control group | Urine | C57BL/6 mouse | Down |
| Study M806 | Type2 | corticosterone + Gleditsiae spina group vs. corticosterone group | Urine | C57BL/6 mouse | Up |
| Study M846 | Type1 | postpartum depression model group vs. control group | Hippocampus | BALB/c mouse | Down |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Hippocampus | BALB/c mouse | Down |
| Study M874 | Type1 | ovariectomy group vs. control group | Urine | Sprague-Dawley rat | Down |
| Study M874 | Type2 | ovariectomy + Panax ginseng group vs. ovariectomy group | Urine | Sprague-Dawley rat | Up |
| Study M927 | Type1 | CUMS group vs. control group | Brain | Sprague-Dawley rat | Down |
| Study M927 | Type2 | CUMS + Zhi-zi-chi decoction group vs. CUMS group | Brain | Sprague-Dawley rat | Up |
| Study M935 | Type2 | chronic social isolation + tianeptine group vs. chronic social isolation group | Hippocampus | Wistar rat | Up |
| Study M935 | Type4 | chronic social isolation + tianeptine group vs. chronic social isolation + tianeptine resilient group | Hippocampus | Wistar rat | Up |
| Study M940 | Type1 | CUMS group vs. control group | Cerebral cortex | Sprague-Dawley rat | Down |
| Study M940 | Type2 | CUMS + Chaihu-Baishao herb pair group vs. CUMS group | Cerebral cortex | Sprague-Dawley rat | Up |
| Study M940 | Type2 | CUMS + Chaihu group vs. CUMS group | Cerebral cortex | Sprague-Dawley rat | Up |
| Study M953 | Type2 | CRS + Shugan Granule group vs. CRS group | Faece | Sprague-Dawley rat | Up |